Search Results 621-630 of 21369 for anti-TNF drugs

1. Study finds lung transplant patients not given antifungal preventive drugs have higher risk of death - Mayo Clinic News Network

   Also, antifungal medications are expensive and can interact with other medications. Therefore, the health care team must monitor anti-fungal medications closely ...

2. Mayo Clinic researchers present findings at the 2019 San Antonio Breast Cancer Symposium

   ... Anti-inflammatory Drugs". Embargoed until Friday, Dec. 13, at 6 p.m. EST. Research from Mayo Clinic investigators suggest that some women with an elevated ...

3. Tryptophan (Oral Route) Before Using - Mayo Clinic

   There is no specific information comparing use of L-tryptophan in the elderly with use in other age groups. Drug Interactions. Although certain medicines should ...

4. Antithymocyte Globulin Rabbit (Intravenous Route) Precautions - Mayo Clinic

   While you are being treated with anti-thymocyte globulin (rabbit), and after you stop treatment with it, it is important to see your doctor about the ...

5. Corticotropin (Intramuscular Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. Descriptions. Repository corticotropin injection is used to treat ...

6. Undecylenic Acid (Topical Route) Description and Brand Names - Mayo Clinic

   However, compound undecylenic acid generally has been replaced by newer and more effective medicines for the treatment of fungus infections.

7. Pegfilgrastim-Bmez (Subcutaneous Route) Description and Brand Names - Mayo Clinic

   Pegfilgrastim-bmez injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a ...

8. Irinotecan (Intravenous Route) Description and Brand Names - Mayo Clinic

   Irinotecan injection is given together with other medicines (eg, 5-fluorouracil, leucovorin) to treat patients with metastatic cancer (a cancer that has already ...

9. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

   Subject who received nonsteroidal anti-inflammatory drugs (NSAIDs) within 7 days prior to Baseline, except topical NSAIDs and low dose aspirin for ...

10. Nilutamide (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...